Simultaneous determination of mercapturic acids derived from ethylene oxide (HEMA), propylene oxide (2-HPMA), acrolein (3-HPMA), acrylamide (AAMA) and N,N-dimethylformamide (AMCC) in human urine using liquid chromatography/tandem mass spectrometry
Mercapturic acids are highly important and specific biomarkers of exposure to carcinogenic substances in occupational and environmental medicine. We have developed and validated a reliable, specific and very sensitive method for the simultaneous determination of five mercapturic acids derived from s...
Saved in:
| Published in | Rapid communications in mass spectrometry Vol. 22; no. 17; pp. 2629 - 2638 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Chichester, UK
John Wiley & Sons, Ltd
15.09.2008
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Mercapturic acids are highly important and specific biomarkers of exposure to carcinogenic substances in occupational and environmental medicine. We have developed and validated a reliable, specific and very sensitive method for the simultaneous determination of five mercapturic acids derived from several high‐production chemicals used in industry, namely ethylene oxide, propylene oxide, acrylamide, acrolein and N,N‐dimethylformamide. Analytes are enriched and cleaned up from urinary matrix by offline solid‐phase extraction. The mercapturic acids are subsequently separated by means of high‐performance liquid chromatography on a Luna C8 (2) column and specifically quantified by tandem mass spectrometric detection using isotopically labelled analytes as internal standards. The limits of detection (LODs) for N‐acetyl‐S‐2‐carbamoylethylcysteine (AAMA) and N‐acetyl‐S‐2‐hydroxyethylcysteine (HEMA) were 2.5 µg/L and 0.5 µg/L urine, while for N‐acetyl‐S‐3‐hydroxypropylcysteine (3‐HPMA), N‐acetyl‐S‐2‐hydroxypropylcysteine (2‐HPMA) and N‐acetyl‐S‐(N‐methylcarbamoyl)cysteine (AMCC) it was 5 µg/L. These LODs were sufficient to detect the background exposure of the general population. We applied the method on spot urine samples of 28 subjects of the general population with no known occupational exposure to these substances. Median levels for AAMA, HEMA, 3‐HPMA, 2‐HPMA and AMCC in non‐smokers (n = 14) were 52.6, 2.0, 155, 7.1 and 113.6 µg/L, respectively. In smokers (n = 14), median levels for AAMA, HEMA, 3‐HPMA, 2‐HPMA and AMCC were 243, 5.3, 1681, 41.7 and 822 µg/L, respectively. Due to the simultaneous quantification of these mercapturic acids, our method is well suited for the screening of workers with multiple chemical exposures as well as the determination of the background excretion of the general population. Copyright © 2008 John Wiley & Sons, Ltd. |
|---|---|
| AbstractList | Mercapturic acids are highly important and specific biomarkers of exposure to carcinogenic substances in occupational and environmental medicine. We have developed and validated a reliable, specific and very sensitive method for the simultaneous determination of five mercapturic acids derived from several high-production chemicals used in industry, namely ethylene oxide, propylene oxide, acrylamide, acrolein and N,N-dimethylformamide. Analytes are enriched and cleaned up from urinary matrix by offline solid-phase extraction. The mercapturic acids are subsequently separated by means of high-performance liquid chromatography on a Luna C8 (2) column and specifically quantified by tandem mass spectrometric detection using isotopically labelled analytes as internal standards. The limits of detection (LODs) for N-acetyl-S-2-carbamoylethylcysteine (AAMA) and N-acetyl-S-2-hydroxyethylcysteine (HEMA) were 2.5 microg/L and 0.5 microg/L urine, while for N-acetyl-S-3-hydroxypropylcysteine (3-HPMA), N-acetyl-S-2-hydroxypropylcysteine (2-HPMA) and N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC) it was 5 microg/L. These LODs were sufficient to detect the background exposure of the general population. We applied the method on spot urine samples of 28 subjects of the general population with no known occupational exposure to these substances. Median levels for AAMA, HEMA, 3-HPMA, 2-HPMA and AMCC in non-smokers (n = 14) were 52.6, 2.0, 155, 7.1 and 113.6 microg/L, respectively. In smokers (n = 14), median levels for AAMA, HEMA, 3-HPMA, 2-HPMA and AMCC were 243, 5.3, 1681, 41.7 and 822 microg/L, respectively. Due to the simultaneous quantification of these mercapturic acids, our method is well suited for the screening of workers with multiple chemical exposures as well as the determination of the background excretion of the general population. Mercapturic acids are highly important and specific biomarkers of exposure to carcinogenic substances in occupational and environmental medicine. We have developed and validated a reliable, specific and very sensitive method for the simultaneous determination of five mercapturic acids derived from several high-production chemicals used in industry, namely ethylene oxide, propylene oxide, acrylamide, acrolein and N,N-dimethylformamide. Analytes are enriched and cleaned up from urinary matrix by offline solid-phase extraction. The mercapturic acids are subsequently separated by means of high-performance liquid chromatography on a Luna C8 (2) column and specifically quantified by tandem mass spectrometric detection using isotopically labelled analytes as internal standards. The limits of detection (LODs) for N-acetyl-S-2-carbamoylethylcysteine (AAMA) and N-acetyl-S-2-hydroxyethylcysteine (HEMA) were 2.5mug/L and 0.5mug/L urine, while for N-acetyl-S-3-hydroxypropylcysteine (3-HPMA), N-acetyl-S-2-hydroxypropylcysteine (2-HPMA) and N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC) it was 5mug/L. These LODs were sufficient to detect the background exposure of the general population. We applied the method on spot urine samples of 28 subjects of the general population with no known occupational exposure to these substances. Median levels for AAMA, HEMA, 3-HPMA, 2-HPMA and AMCC in non-smokers (n=14) were 52.6, 2.0, 155, 7.1 and 113.6mug/L, respectively. In smokers (n=14), median levels for AAMA, HEMA, 3-HPMA, 2-HPMA and AMCC were 243, 5.3, 1681, 41.7 and 822mug/L, respectively. Due to the simultaneous quantification of these mercapturic acids, our method is well suited for the screening of workers with multiple chemical exposures as well as the determination of the background excretion of the general population. Mercapturic acids are highly important and specific biomarkers of exposure to carcinogenic substances in occupational and environmental medicine. We have developed and validated a reliable, specific and very sensitive method for the simultaneous determination of five mercapturic acids derived from several high‐production chemicals used in industry, namely ethylene oxide, propylene oxide, acrylamide, acrolein and N,N‐dimethylformamide. Analytes are enriched and cleaned up from urinary matrix by offline solid‐phase extraction. The mercapturic acids are subsequently separated by means of high‐performance liquid chromatography on a Luna C8 (2) column and specifically quantified by tandem mass spectrometric detection using isotopically labelled analytes as internal standards. The limits of detection (LODs) for N‐acetyl‐S‐2‐carbamoylethylcysteine (AAMA) and N‐acetyl‐S‐2‐hydroxyethylcysteine (HEMA) were 2.5 µg/L and 0.5 µg/L urine, while for N‐acetyl‐S‐3‐hydroxypropylcysteine (3‐HPMA), N‐acetyl‐S‐2‐hydroxypropylcysteine (2‐HPMA) and N‐acetyl‐S‐(N‐methylcarbamoyl)cysteine (AMCC) it was 5 µg/L. These LODs were sufficient to detect the background exposure of the general population. We applied the method on spot urine samples of 28 subjects of the general population with no known occupational exposure to these substances. Median levels for AAMA, HEMA, 3‐HPMA, 2‐HPMA and AMCC in non‐smokers (n = 14) were 52.6, 2.0, 155, 7.1 and 113.6 µg/L, respectively. In smokers (n = 14), median levels for AAMA, HEMA, 3‐HPMA, 2‐HPMA and AMCC were 243, 5.3, 1681, 41.7 and 822 µg/L, respectively. Due to the simultaneous quantification of these mercapturic acids, our method is well suited for the screening of workers with multiple chemical exposures as well as the determination of the background excretion of the general population. Copyright © 2008 John Wiley & Sons, Ltd. Mercapturic acids are highly important and specific biomarkers of exposure to carcinogenic substances in occupational and environmental medicine. We have developed and validated a reliable, specific and very sensitive method for the simultaneous determination of five mercapturic acids derived from several high-production chemicals used in industry, namely ethylene oxide, propylene oxide, acrylamide, acrolein and N,N-dimethylformamide. Analytes are enriched and cleaned up from urinary matrix by offline solid-phase extraction. The mercapturic acids are subsequently separated by means of high-performance liquid chromatography on a Luna C8 (2) column and specifically quantified by tandem mass spectrometric detection using isotopically labelled analytes as internal standards. The limits of detection (LODs) for N-acetyl-S-2-carbamoylethylcysteine (AAMA) and N-acetyl-S-2-hydroxyethylcysteine (HEMA) were 2.5 microg/L and 0.5 microg/L urine, while for N-acetyl-S-3-hydroxypropylcysteine (3-HPMA), N-acetyl-S-2-hydroxypropylcysteine (2-HPMA) and N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC) it was 5 microg/L. These LODs were sufficient to detect the background exposure of the general population. We applied the method on spot urine samples of 28 subjects of the general population with no known occupational exposure to these substances. Median levels for AAMA, HEMA, 3-HPMA, 2-HPMA and AMCC in non-smokers (n = 14) were 52.6, 2.0, 155, 7.1 and 113.6 microg/L, respectively. In smokers (n = 14), median levels for AAMA, HEMA, 3-HPMA, 2-HPMA and AMCC were 243, 5.3, 1681, 41.7 and 822 microg/L, respectively. Due to the simultaneous quantification of these mercapturic acids, our method is well suited for the screening of workers with multiple chemical exposures as well as the determination of the background excretion of the general population.Mercapturic acids are highly important and specific biomarkers of exposure to carcinogenic substances in occupational and environmental medicine. We have developed and validated a reliable, specific and very sensitive method for the simultaneous determination of five mercapturic acids derived from several high-production chemicals used in industry, namely ethylene oxide, propylene oxide, acrylamide, acrolein and N,N-dimethylformamide. Analytes are enriched and cleaned up from urinary matrix by offline solid-phase extraction. The mercapturic acids are subsequently separated by means of high-performance liquid chromatography on a Luna C8 (2) column and specifically quantified by tandem mass spectrometric detection using isotopically labelled analytes as internal standards. The limits of detection (LODs) for N-acetyl-S-2-carbamoylethylcysteine (AAMA) and N-acetyl-S-2-hydroxyethylcysteine (HEMA) were 2.5 microg/L and 0.5 microg/L urine, while for N-acetyl-S-3-hydroxypropylcysteine (3-HPMA), N-acetyl-S-2-hydroxypropylcysteine (2-HPMA) and N-acetyl-S-(N-methylcarbamoyl)cysteine (AMCC) it was 5 microg/L. These LODs were sufficient to detect the background exposure of the general population. We applied the method on spot urine samples of 28 subjects of the general population with no known occupational exposure to these substances. Median levels for AAMA, HEMA, 3-HPMA, 2-HPMA and AMCC in non-smokers (n = 14) were 52.6, 2.0, 155, 7.1 and 113.6 microg/L, respectively. In smokers (n = 14), median levels for AAMA, HEMA, 3-HPMA, 2-HPMA and AMCC were 243, 5.3, 1681, 41.7 and 822 microg/L, respectively. Due to the simultaneous quantification of these mercapturic acids, our method is well suited for the screening of workers with multiple chemical exposures as well as the determination of the background excretion of the general population. Mercapturic acids are highly important and specific biomarkers of exposure to carcinogenic substances in occupational and environmental medicine. We have developed and validated a reliable, specific and very sensitive method for the simultaneous determination of five mercapturic acids derived from several high‐production chemicals used in industry, namely ethylene oxide, propylene oxide, acrylamide, acrolein and N,N ‐dimethylformamide. Analytes are enriched and cleaned up from urinary matrix by offline solid‐phase extraction. The mercapturic acids are subsequently separated by means of high‐performance liquid chromatography on a Luna C8 (2) column and specifically quantified by tandem mass spectrometric detection using isotopically labelled analytes as internal standards. The limits of detection (LODs) for N ‐acetyl‐ S ‐2‐carbamoylethylcysteine (AAMA) and N ‐acetyl‐ S ‐2‐hydroxyethylcysteine (HEMA) were 2.5 µg/L and 0.5 µg/L urine, while for N ‐acetyl‐ S ‐3‐hydroxypropylcysteine (3‐HPMA), N ‐acetyl‐ S ‐2‐hydroxypropylcysteine (2‐HPMA) and N ‐acetyl‐ S ‐( N ‐methylcarbamoyl)cysteine (AMCC) it was 5 µg/L. These LODs were sufficient to detect the background exposure of the general population. We applied the method on spot urine samples of 28 subjects of the general population with no known occupational exposure to these substances. Median levels for AAMA, HEMA, 3‐HPMA, 2‐HPMA and AMCC in non‐smokers (n = 14) were 52.6, 2.0, 155, 7.1 and 113.6 µg/L, respectively. In smokers (n = 14), median levels for AAMA, HEMA, 3‐HPMA, 2‐HPMA and AMCC were 243, 5.3, 1681, 41.7 and 822 µg/L, respectively. Due to the simultaneous quantification of these mercapturic acids, our method is well suited for the screening of workers with multiple chemical exposures as well as the determination of the background excretion of the general population. Copyright © 2008 John Wiley & Sons, Ltd. |
| Author | Kraus, Thomas Schettgen, Thomas Musiol, Anita |
| Author_xml | – sequence: 1 givenname: Thomas surname: Schettgen fullname: Schettgen, Thomas email: tschettgen@ukaachen.de organization: Institute and Outpatient Clinic for Occupational and Social Medicine, University Hospital, Aachen University of Technology, Pauwelsstrasse 30, D-52074 Aachen, Germany – sequence: 2 givenname: Anita surname: Musiol fullname: Musiol, Anita organization: Institute and Outpatient Clinic for Occupational and Social Medicine, University Hospital, Aachen University of Technology, Pauwelsstrasse 30, D-52074 Aachen, Germany – sequence: 3 givenname: Thomas surname: Kraus fullname: Kraus, Thomas organization: Institute and Outpatient Clinic for Occupational and Social Medicine, University Hospital, Aachen University of Technology, Pauwelsstrasse 30, D-52074 Aachen, Germany |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18666198$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkt9v0zAQxyM0xLqBxF-A_IQ6aekcJ3Hqx6obK9JafgyEtBfLsS-rIU4y24HlL-cVt92AIRBPlr73ubuv7-4g2mvaBqLoeYInCcbkxEozSWnOHkWjBLMixiRN9qIRZnkSZwmb7kcHzn3GOElygp9E-8mUUhr0UfT9Upu-9qKBtndIgQdrdCO8bhvUVsiAlaLzvdUSCanVBrH6KyhU2dYg8OuhhgZQe6sVoPHibDk7OkadbbsHOokXb7cRIW1bg27QOP1NGmphttxsFiQkGoVWx6tYabNtULXW3APL-fwIhfx1b0SDgq_QpHe6uUa1vum1QnIdjAnfXlvRrYeT8DMFBhnhHHIdSB-i4O3wNHpcidrBs7v3MPr46uzDfBFfvDl_PZ9dxDLLMxYnFSupYkSUBKhQKcYVwxmjdCoJFlhKlmVE5GUKtKK0rEpBlGAVFIywvMzy9DB6uasbZnLTg_PcaCehrncT55RlCSEZ_S-YBj9ZWhQBfHEH9qUBxTurjbADv99pAMY7IMzaOQvVLwTzzbnwcC58cy4BnfyBSu23y_dW6PpvCfEu4ZuuYfhnYf5-vnzIa-fh9icv7BdOi7TI-afVOZ--u2TZ6eKKX6U_ACjw4bU |
| CitedBy_id | crossref_primary_10_1002_jms_1309 crossref_primary_10_1016_j_aca_2015_08_033 crossref_primary_10_1289_ehp_1409251 crossref_primary_10_1007_s00216_019_02166_6 crossref_primary_10_1016_j_bbr_2021_113405 crossref_primary_10_1016_j_jchromb_2009_11_043 crossref_primary_10_1016_j_chroma_2017_08_030 crossref_primary_10_1007_s11356_023_29418_4 crossref_primary_10_1002_mnfr_201900849 crossref_primary_10_1016_j_jchromb_2010_02_023 crossref_primary_10_3390_toxics11100816 crossref_primary_10_3109_10408444_2012_725028 crossref_primary_10_1007_s00216_015_8719_x crossref_primary_10_2903_j_efsa_2015_4104 crossref_primary_10_1016_j_toxlet_2020_03_010 crossref_primary_10_1016_j_aca_2012_04_009 crossref_primary_10_1002_dta_2 crossref_primary_10_1089_neu_2013_2888 crossref_primary_10_1038_jes_2010_4 crossref_primary_10_3389_fneur_2018_00420 crossref_primary_10_1016_j_ijheh_2021_113749 crossref_primary_10_1016_j_chemosphere_2022_133880 crossref_primary_10_3109_1354750X_2016_1141988 crossref_primary_10_1002_dta_3372 crossref_primary_10_1002_14651858_CD013790_pub2 crossref_primary_10_1016_j_talanta_2012_06_074 crossref_primary_10_1002_mnfr_201200323 crossref_primary_10_1016_j_jchromb_2009_09_003 crossref_primary_10_3390_toxics10060298 crossref_primary_10_1039_D4AY00444B crossref_primary_10_1002_mnfr_201300418 crossref_primary_10_1039_C4AY03058C crossref_primary_10_1515_cttr_2017_0006 crossref_primary_10_1002_jccs_201300275 crossref_primary_10_1161_JAHA_114_000934 crossref_primary_10_1007_s11356_020_12135_7 crossref_primary_10_1515_cttr_2016_0006 crossref_primary_10_1016_j_jchromb_2014_02_001 crossref_primary_10_1007_s00204_017_2143_2 crossref_primary_10_1021_tx2001306 crossref_primary_10_1016_j_atmosenv_2014_08_030 crossref_primary_10_1007_s12264_014_1480_x crossref_primary_10_1016_j_ab_2012_07_026 crossref_primary_10_1016_j_jchromb_2014_07_013 crossref_primary_10_1007_s00216_011_5661_4 crossref_primary_10_1002_mnfr_201100481 crossref_primary_10_1038_srep45067 crossref_primary_10_1021_acs_chemrestox_4c00446 crossref_primary_10_1248_bpb_b15_01022 crossref_primary_10_1093_ntr_ntx133 crossref_primary_10_3390_ijerph17051801 crossref_primary_10_1586_14737175_2014_918849 crossref_primary_10_1007_s10337_015_2878_y crossref_primary_10_1016_j_jns_2017_05_039 crossref_primary_10_1016_j_jchromb_2014_02_057 crossref_primary_10_1371_journal_pone_0124841 crossref_primary_10_1002_14651858_CD013790 crossref_primary_10_1016_j_envres_2021_111832 crossref_primary_10_1093_chromsci_bmt106 crossref_primary_10_1016_j_envpol_2021_118469 crossref_primary_10_1016_j_jchromb_2013_07_004 crossref_primary_10_1016_j_ijheh_2011_03_001 |
| Cites_doi | 10.1093/jat/22.2.96 10.1016/S0890-6238(99)00011-8 10.1016/S0378-4347(00)00385-6 10.1016/S0378-4274(02)00164-9 10.1007/s004200050016 10.1016/S0378-4347(99)00372-2 10.1007/s00420-005-0620-z 10.1007/BF00316366 10.1002/em.2850160302 10.1016/j.jchromb.2008.01.024 10.1016/j.mrgentox.2004.11.010 10.1016/j.jchromb.2005.07.042 10.1002/jat.2550090406 10.1038/sj.jea.7500032 10.1016/j.jpba.2004.10.001 10.1016/0378-4347(87)80064-6 10.1016/S0378-4347(01)00242-0 10.1021/tx700075y 10.1158/1055-9965.EPI-06-0915 10.1016/j.etp.2006.07.001 10.1039/a903039e 10.1021/jf020302f 10.1016/j.chroma.2006.07.026 10.1007/BF00381474 10.1002/rcm.1565 10.1016/0009-8981(72)90513-X |
| ContentType | Journal Article |
| Copyright | Copyright © 2008 John Wiley & Sons, Ltd. |
| Copyright_xml | – notice: Copyright © 2008 John Wiley & Sons, Ltd. |
| DBID | BSCLL AAYXX CITATION CGR CUY CVF ECM EIF NPM 7SR 7U5 8BQ 8FD JG9 L7M 7X8 |
| DOI | 10.1002/rcm.3659 |
| DatabaseName | Istex CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Engineered Materials Abstracts Solid State and Superconductivity Abstracts METADEX Technology Research Database Materials Research Database Advanced Technologies Database with Aerospace MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Materials Research Database Engineered Materials Abstracts Solid State and Superconductivity Abstracts Technology Research Database Advanced Technologies Database with Aerospace METADEX MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Materials Research Database MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 1097-0231 |
| EndPage | 2638 |
| ExternalDocumentID | 18666198 10_1002_rcm_3659 RCM3659 ark_67375_WNG_8QS94DHZ_Z |
| Genre | article Journal Article |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52W 52X 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABIJN ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACIWK ACPOU ACXBN ACXQS ADBBV ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFZJQ AHBTC AITYG AIURR AIWBW AJBDE AJXKR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AUFTA AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMNLL BMXJE BNHUX BROTX BRXPI BSCLL BY8 CS3 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRSTM DU5 EBS EJD F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.T H.X HBH HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRSTM MSFUL MSSTM MXFUL MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG P2P P2W P2X P4D Q.N Q11 QB0 QRW R.K RNS ROL RWI RX1 RYL SUPJJ TN5 UB1 V2E W8V W99 WBFHL WBKPD WH7 WIB WIH WIK WJL WOHZO WQJ WRC WRJ WXSBR WYISQ XG1 XPP XV2 ZZTAW ~02 ~IA ~WT AAHQN AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGQPQ AGYGG CITATION 53G AAMMB ABEML ACSCC AEFGJ AGHNM AGXDD AIDQK AIDYY AQPKS CGR CUY CVF EBD ECM EIF EMOBN HF~ LH5 NPM PALCI RIWAO RJQFR SAMSI ZCG 7SR 7U5 8BQ 8FD JG9 L7M 7X8 |
| ID | FETCH-LOGICAL-c4549-1f9b6d92ab2e6ad300f9049668c20a0cc9442a5b3e6f66bfba2da9fe79295b453 |
| IEDL.DBID | DR2 |
| ISSN | 0951-4198 |
| IngestDate | Fri Jul 11 09:25:19 EDT 2025 Fri Jul 11 04:39:41 EDT 2025 Mon Jul 21 06:04:09 EDT 2025 Tue Jul 01 02:10:41 EDT 2025 Thu Apr 24 23:12:42 EDT 2025 Wed Jan 22 16:19:17 EST 2025 Wed Oct 30 09:51:03 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 17 |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4549-1f9b6d92ab2e6ad300f9049668c20a0cc9442a5b3e6f66bfba2da9fe79295b453 |
| Notes | ark:/67375/WNG-8QS94DHZ-Z ArticleID:RCM3659 istex:365DB4E55813C59986096EE0E5B5FD9D126F40E3 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
| PMID | 18666198 |
| PQID | 34544377 |
| PQPubID | 23500 |
| PageCount | 10 |
| ParticipantIDs | proquest_miscellaneous_69412246 proquest_miscellaneous_34544377 pubmed_primary_18666198 crossref_primary_10_1002_rcm_3659 crossref_citationtrail_10_1002_rcm_3659 wiley_primary_10_1002_rcm_3659_RCM3659 istex_primary_ark_67375_WNG_8QS94DHZ_Z |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 15 September 2008 |
| PublicationDateYYYYMMDD | 2008-09-15 |
| PublicationDate_xml | – month: 09 year: 2008 text: 15 September 2008 day: 15 |
| PublicationDecade | 2000 |
| PublicationPlace | Chichester, UK |
| PublicationPlace_xml | – name: Chichester, UK – name: England |
| PublicationTitle | Rapid communications in mass spectrometry |
| PublicationTitleAlternate | Rapid Commun. Mass Spectrom |
| PublicationYear | 2008 |
| Publisher | John Wiley & Sons, Ltd |
| Publisher_xml | – name: John Wiley & Sons, Ltd |
| References | IARC. IARC Monograph Eval. Carcinog. Risks Hum. 1994; 60: 389. Sohn JH, Han MJ, Lee MY, Kang SK, Yang JS. J. Pharm. Biomed. Anal. 2005; 37: 165. Vermeulen NPE, de Jong J, van Bergen EJC, van Welie RTH. Arch. Toxicol. 1989; 63: 173. Käfferlein HU, Göen T, Müller J, Wrbitzky R, Angerer J. Int. Arch. Occup. Environ. Health 2000; 73: 113. Römpp Chemie Lexikon, (8th edn). Franckh'sche Verlagshandlung: Stuttgart, 1987. DFG (Deutsche Forschungsgemeinschaft). List of MAK- and BAT-values, 2006; Wiley-VCH: Weinheim, 2006. Haufroid V, Lison D. Int. Arch. Occup. Environ. Health 2005; 78: 343. IARC. IARC Monograph Eval. Carcinog. Risks Hum. 1994; 60: 73. Calafat AM, Barr DB, Pirkle JL, Ashley DL. J. Expo. Anal. Environ. Epidemiol. 1999; 9: 336. Sanduja R, Ansari GAS, Boor PJ. J. Appl. Toxicol. 1989; 9: 235. Böttcher MI, Schettgen T, Kütting B, Pischetsrieder M, Angerer J. Mutat. Res. 2005; 580: 167. Perbellini M, Maestri L, Veronese N, Romani S, Brugnone F. J. Chromatogr. B. Biomed. Sci. Appl. 2001; 759: 349. Scherer G. Exp. Toxicol. Pathol. 2006; 58: 101. Larsen K. Clin. Chim. Acta 1972; 41: 209. Sega GA, Generoso EE, Brimer PA. Env. Mol. Mutagen. 1990; 16: 137. Käfferlein HU, Angerer J. J. Chromatogr. B. Biomed. Sci. Appl. 1999; 734: 285. Schettgen T, Musiol A, Alt A, Kraus T. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2008; 863: 283. Holland N, Ahlborn T, Turteltaub K, Markee C, Moore D, Wyrobek AJ, Smith MT. Reprod. Toxicol. 1999; 13: 167. Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M. J. Agric. Food Chem. 2002; 50: 4998. Haufroid V, Merz B, Hofmann A, Tschopp A, Lison D, Hotz P. Cancer Epidemiol. Biomarkers Prev. 2007; 16: 796. Mraz J, Turecek F. J. Chromatogr. 1987; 414: 399. Schettgen T, Broding HC, Angerer J, Drexler H. Toxicol. Lett. 2002; 134: 65. Carmella SG, Chen M, Zhang Y, Zhang S, Hatsukami DK, Hecht SS. Chem. Res. Toxicol. 2007; 20: 986. Perico A, Baglioni S, Bavazzano P. Rapid Commun. Mass Spectrom. 2004; 18: 1865. Böttcher MI, Angerer J. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2005; 824: 283. IARC. IARC Monograph Eval. Carcinog. Risks Hum. 1994; 60: 181. IARC. IARC Monograph Eval. Carcinog. Risks Hum. 1995; 63: 337. Mraz J, Nohova H. Int. Arch. Occup. Environ. Health 1992; 64: 85. Kellert M, Scholz K, Wagner S, Dekant W, Völkel W. J. Chromatogr. A 2006; 1131: 58. Mascher DG, Mascher HJ, Scherer G, Schmid ER. J. Chromatogr. B. Biomed. Sci. Appl. 2001; 750: 163. Zil-a-Rubab, Rahman MA. J. Pak. Med. Assoc. 2006; 56: 323. Barr DB, Ashley DL. J. Anal. Toxicol. 1998; 22: 96. Käfferlein HU, Angerer J. J. Environ. Monit. 1999; 1: 465. 1989; 63 2006; 56 1990; 16 2002; 50 1989; 9 2006; 58 2002; 134 2000; 73 2006 2005 2008; 863 1972; 41 1999; 1 1994; 60 1998; 22 1999; 9 2007; 16 1995; 63 2001; 750 2005; 580 2004; 18 1987; 414 2003; 8 1987 1999; 13 2005; 824 2007; 20 1992; 64 2005; 37 1999; 734 2006; 1131 2001; 759 2005; 78 e_1_2_6_30_2 DFG (Deutsche Forschungsgemeinschaft) (e_1_2_6_11_2) 2006 (e_1_2_6_9_2) 1987 e_1_2_6_18_2 e_1_2_6_19_2 Müller M (e_1_2_6_31_2) 2003 e_1_2_6_35_2 e_1_2_6_13_2 e_1_2_6_34_2 e_1_2_6_10_2 e_1_2_6_33_2 e_1_2_6_32_2 e_1_2_6_17_2 e_1_2_6_14_2 e_1_2_6_15_2 e_1_2_6_36_2 e_1_2_6_20_2 IARC (e_1_2_6_8_2) 1994; 60 IARC (e_1_2_6_16_2) 1994; 60 Zil‐a‐Rubab (e_1_2_6_37_2) 2006; 56 IARC (e_1_2_6_12_2) 1995; 63 e_1_2_6_7_2 e_1_2_6_29_2 e_1_2_6_4_2 e_1_2_6_6_2 e_1_2_6_5_2 e_1_2_6_24_2 e_1_2_6_23_2 e_1_2_6_2_2 e_1_2_6_22_2 e_1_2_6_21_2 IARC (e_1_2_6_3_2) 1994; 60 e_1_2_6_28_2 e_1_2_6_27_2 e_1_2_6_26_2 e_1_2_6_25_2 |
| References_xml | – reference: Käfferlein HU, Angerer J. J. Environ. Monit. 1999; 1: 465. – reference: Sanduja R, Ansari GAS, Boor PJ. J. Appl. Toxicol. 1989; 9: 235. – reference: Haufroid V, Lison D. Int. Arch. Occup. Environ. Health 2005; 78: 343. – reference: Barr DB, Ashley DL. J. Anal. Toxicol. 1998; 22: 96. – reference: DFG (Deutsche Forschungsgemeinschaft). List of MAK- and BAT-values, 2006; Wiley-VCH: Weinheim, 2006. – reference: Kellert M, Scholz K, Wagner S, Dekant W, Völkel W. J. Chromatogr. A 2006; 1131: 58. – reference: Römpp Chemie Lexikon, (8th edn). Franckh'sche Verlagshandlung: Stuttgart, 1987. – reference: Zil-a-Rubab, Rahman MA. J. Pak. Med. Assoc. 2006; 56: 323. – reference: Haufroid V, Merz B, Hofmann A, Tschopp A, Lison D, Hotz P. Cancer Epidemiol. Biomarkers Prev. 2007; 16: 796. – reference: Böttcher MI, Schettgen T, Kütting B, Pischetsrieder M, Angerer J. Mutat. Res. 2005; 580: 167. – reference: Sohn JH, Han MJ, Lee MY, Kang SK, Yang JS. J. Pharm. Biomed. Anal. 2005; 37: 165. – reference: Perico A, Baglioni S, Bavazzano P. Rapid Commun. Mass Spectrom. 2004; 18: 1865. – reference: Käfferlein HU, Angerer J. J. Chromatogr. B. Biomed. Sci. Appl. 1999; 734: 285. – reference: Calafat AM, Barr DB, Pirkle JL, Ashley DL. J. Expo. Anal. Environ. Epidemiol. 1999; 9: 336. – reference: Mascher DG, Mascher HJ, Scherer G, Schmid ER. J. Chromatogr. B. Biomed. Sci. Appl. 2001; 750: 163. – reference: Böttcher MI, Angerer J. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2005; 824: 283. – reference: Larsen K. Clin. Chim. Acta 1972; 41: 209. – reference: IARC. IARC Monograph Eval. Carcinog. Risks Hum. 1995; 63: 337. – reference: Mraz J, Turecek F. J. Chromatogr. 1987; 414: 399. – reference: Käfferlein HU, Göen T, Müller J, Wrbitzky R, Angerer J. Int. Arch. Occup. Environ. Health 2000; 73: 113. – reference: Holland N, Ahlborn T, Turteltaub K, Markee C, Moore D, Wyrobek AJ, Smith MT. Reprod. Toxicol. 1999; 13: 167. – reference: Mraz J, Nohova H. Int. Arch. Occup. Environ. Health 1992; 64: 85. – reference: Perbellini M, Maestri L, Veronese N, Romani S, Brugnone F. J. Chromatogr. B. Biomed. Sci. Appl. 2001; 759: 349. – reference: Schettgen T, Broding HC, Angerer J, Drexler H. Toxicol. Lett. 2002; 134: 65. – reference: Vermeulen NPE, de Jong J, van Bergen EJC, van Welie RTH. Arch. Toxicol. 1989; 63: 173. – reference: Carmella SG, Chen M, Zhang Y, Zhang S, Hatsukami DK, Hecht SS. Chem. Res. Toxicol. 2007; 20: 986. – reference: Sega GA, Generoso EE, Brimer PA. Env. Mol. Mutagen. 1990; 16: 137. – reference: Schettgen T, Musiol A, Alt A, Kraus T. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 2008; 863: 283. – reference: IARC. IARC Monograph Eval. Carcinog. Risks Hum. 1994; 60: 73. – reference: IARC. IARC Monograph Eval. Carcinog. Risks Hum. 1994; 60: 181. – reference: IARC. IARC Monograph Eval. Carcinog. Risks Hum. 1994; 60: 389. – reference: Tareke E, Rydberg P, Karlsson P, Eriksson S, Törnqvist M. J. Agric. Food Chem. 2002; 50: 4998. – reference: Scherer G. Exp. Toxicol. Pathol. 2006; 58: 101. – volume: 64 start-page: 85 year: 1992 publication-title: Int. Arch. Occup. Environ. Health – volume: 63 start-page: 173 year: 1989 publication-title: Arch. Toxicol. – volume: 580 start-page: 167 year: 2005 publication-title: Mutat. Res. – volume: 18 start-page: 1865 year: 2004 publication-title: Rapid Commun. Mass Spectrom. – volume: 37 start-page: 165 year: 2005 publication-title: J. Pharm. Biomed. Anal. – year: 2005 – volume: 8 start-page: 53 year: 2003 – volume: 750 start-page: 163 year: 2001 publication-title: J. Chromatogr. B. Biomed. Sci. Appl. – year: 1987 – volume: 13 start-page: 167 year: 1999 publication-title: Reprod. Toxicol. – volume: 9 start-page: 336 year: 1999 publication-title: J. Expo. Anal. Environ. Epidemiol. – volume: 60 start-page: 389 year: 1994 publication-title: IARC Monograph Eval. Carcinog. Risks Hum. – volume: 73 start-page: 113 year: 2000 publication-title: Int. Arch. Occup. Environ. Health – volume: 16 start-page: 137 year: 1990 publication-title: Env. Mol. Mutagen. – volume: 759 start-page: 349 year: 2001 publication-title: J. Chromatogr. B. Biomed. Sci. Appl. – volume: 63 start-page: 337 year: 1995 publication-title: IARC Monograph Eval. Carcinog. Risks Hum. – volume: 56 start-page: 323 year: 2006 publication-title: J. Pak. Med. Assoc. – volume: 414 start-page: 399 year: 1987 publication-title: J. Chromatogr. – volume: 863 start-page: 283 year: 2008 publication-title: J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. – volume: 1 start-page: 465 year: 1999 publication-title: J. Environ. Monit. – volume: 134 start-page: 65 year: 2002 publication-title: Toxicol. Lett. – volume: 60 start-page: 181 year: 1994 publication-title: IARC Monograph Eval. Carcinog. Risks Hum. – volume: 22 start-page: 96 year: 1998 publication-title: J. Anal. Toxicol. – volume: 1131 start-page: 58 year: 2006 publication-title: J. Chromatogr. A – volume: 58 start-page: 101 year: 2006 publication-title: Exp. Toxicol. Pathol. – year: 2006 – volume: 734 start-page: 285 year: 1999 publication-title: J. Chromatogr. B. Biomed. Sci. Appl. – volume: 824 start-page: 283 year: 2005 publication-title: J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. – volume: 41 start-page: 209 year: 1972 publication-title: Clin. Chim. Acta – volume: 20 start-page: 986 year: 2007 publication-title: Chem. Res. Toxicol. – volume: 60 start-page: 73 year: 1994 publication-title: IARC Monograph Eval. Carcinog. Risks Hum. – volume: 9 start-page: 235 year: 1989 publication-title: J. Appl. Toxicol. – volume: 50 start-page: 4998 year: 2002 publication-title: J. Agric. Food Chem. – volume: 16 start-page: 796 year: 2007 publication-title: Cancer Epidemiol. Biomarkers Prev. – volume: 78 start-page: 343 year: 2005 publication-title: Int. Arch. Occup. Environ. Health – ident: e_1_2_6_5_2 doi: 10.1093/jat/22.2.96 – ident: e_1_2_6_18_2 doi: 10.1016/S0890-6238(99)00011-8 – ident: e_1_2_6_10_2 doi: 10.1016/S0378-4347(00)00385-6 – volume-title: List of MAK‐ and BAT‐values year: 2006 ident: e_1_2_6_11_2 – volume: 60 start-page: 389 year: 1994 ident: e_1_2_6_16_2 publication-title: IARC Monograph Eval. Carcinog. Risks Hum. – ident: e_1_2_6_30_2 doi: 10.1016/S0378-4274(02)00164-9 – ident: e_1_2_6_15_2 – ident: e_1_2_6_22_2 doi: 10.1007/s004200050016 – ident: e_1_2_6_26_2 doi: 10.1016/S0378-4347(99)00372-2 – ident: e_1_2_6_2_2 doi: 10.1007/s00420-005-0620-z – volume: 63 start-page: 337 year: 1995 ident: e_1_2_6_12_2 publication-title: IARC Monograph Eval. Carcinog. Risks Hum. – ident: e_1_2_6_4_2 doi: 10.1007/BF00316366 – start-page: 53 volume-title: Analyses of Hazardous Substances in Biological Materials year: 2003 ident: e_1_2_6_31_2 – ident: e_1_2_6_17_2 doi: 10.1002/em.2850160302 – volume-title: Römpp Chemie Lexikon year: 1987 ident: e_1_2_6_9_2 – ident: e_1_2_6_34_2 doi: 10.1016/j.jchromb.2008.01.024 – ident: e_1_2_6_20_2 doi: 10.1016/j.mrgentox.2004.11.010 – ident: e_1_2_6_33_2 doi: 10.1016/j.jchromb.2005.07.042 – ident: e_1_2_6_13_2 doi: 10.1002/jat.2550090406 – volume: 60 start-page: 181 year: 1994 ident: e_1_2_6_8_2 publication-title: IARC Monograph Eval. Carcinog. Risks Hum. – ident: e_1_2_6_6_2 doi: 10.1038/sj.jea.7500032 – ident: e_1_2_6_29_2 doi: 10.1016/j.jpba.2004.10.001 – ident: e_1_2_6_23_2 doi: 10.1016/0378-4347(87)80064-6 – volume: 60 start-page: 73 year: 1994 ident: e_1_2_6_3_2 publication-title: IARC Monograph Eval. Carcinog. Risks Hum. – volume: 56 start-page: 323 year: 2006 ident: e_1_2_6_37_2 publication-title: J. Pak. Med. Assoc. – ident: e_1_2_6_27_2 doi: 10.1016/S0378-4347(01)00242-0 – ident: e_1_2_6_14_2 doi: 10.1021/tx700075y – ident: e_1_2_6_7_2 doi: 10.1158/1055-9965.EPI-06-0915 – ident: e_1_2_6_36_2 doi: 10.1016/j.etp.2006.07.001 – ident: e_1_2_6_35_2 doi: 10.1039/a903039e – ident: e_1_2_6_19_2 doi: 10.1021/jf020302f – ident: e_1_2_6_21_2 doi: 10.1016/j.chroma.2006.07.026 – ident: e_1_2_6_24_2 doi: 10.1007/BF00381474 – ident: e_1_2_6_28_2 doi: 10.1002/rcm.1565 – ident: e_1_2_6_25_2 – ident: e_1_2_6_32_2 doi: 10.1016/0009-8981(72)90513-X |
| SSID | ssj0011520 |
| Score | 2.1576014 |
| Snippet | Mercapturic acids are highly important and specific biomarkers of exposure to carcinogenic substances in occupational and environmental medicine. We have... |
| SourceID | proquest pubmed crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 2629 |
| SubjectTerms | Acetylcysteine - urine Acrolein - chemistry Acrolein - urine Acrylamide - chemistry Acrylamide - urine Adult Biomarkers - urine Chromatography, High Pressure Liquid Dimethylformamide - analysis Dimethylformamide - chemistry Environmental Monitoring - methods Epoxy Compounds - chemistry Epoxy Compounds - urine Ethylene Oxide - chemistry Ethylene Oxide - urine Female Humans Male Middle Aged Occupational Exposure - analysis Spectrometry, Mass, Electrospray Ionization - methods Tandem Mass Spectrometry - methods |
| Title | Simultaneous determination of mercapturic acids derived from ethylene oxide (HEMA), propylene oxide (2-HPMA), acrolein (3-HPMA), acrylamide (AAMA) and N,N-dimethylformamide (AMCC) in human urine using liquid chromatography/tandem mass spectrometry |
| URI | https://api.istex.fr/ark:/67375/WNG-8QS94DHZ-Z/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Frcm.3659 https://www.ncbi.nlm.nih.gov/pubmed/18666198 https://www.proquest.com/docview/34544377 https://www.proquest.com/docview/69412246 |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2h8gAv3C_hukgIGqlOHHu9th8j02IhJYKWiqp9sPZmsFo7wU2kwhOfwDfyH0jMrO1UQa2EeIgiOZNk1nvWc8aeOUvIy1xB2Mpd5uiQC4cJL3Ai7fpOLCOgr5EQzMdu5MmUp_vs3UFw0FZVYi9Mow-xuuGGK8Ner3GBC3k6PBcNrVU58HmAvXtYqoV8aHelHAU8p1FkxF3kGSTWne6s6w27L65Foqt4Us8uopnrrNWGnZ2b5KhzuKk2OR4sF3Kgvv-l5fh_I7pFbrRslI4b-NwmV0x1h1xLuk3g7pLfewWWHIrKzJanVHe1MzibdJbT0tRKzBeoTESFKjSa1HD91BTbVqgBFEBUM3R2VmhDN9Ptybi_RWEw87Xj3q8fP9P39jOhsN6xqOimv3bwGyDX2o4hSvSpqDSdbk3BRBel_RtLvluTSZL0KfyG3YCQ4vMEQ7HA_zM9Kb4uC03VF3BPLFq57iHeTjElLSGRoLb1FDUcYPz3yP7O9sckddodIxzFINF1RnksuY49IT3DhfZdN48hBeI8Up4rXKVixjwRSN_wnHOZS-FpEecmBJIYSBb498lGNavMQwKni7vSCHjJCAV6olGopAzdGBgl89y4R1536MlUK6eOu3qcZI0QtJfBdGY4nT3yYmU5byRELrB5ZQG4MhD1MZbchUH2afo2iz7sxexNepgd9sjzDqEZQAGf7jQQyHyGUoZheLkF9iyjfmCPPGigfe5OBFksrBJwwwL0Uj-z3WSC74_-1fAxud5V2IyCJ2RjUS_NU6BxC_nMLtg_OilJuA |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtNAEF2V9qG8cL-EWxcJQSvViWOv17Z4ikKLgSaCXtSqQlrtzWC1cUJIpMITn8A38h9IzKzjVEGthHiILDnjZNZ71jOznjlDyLNcg9nKfeaZmEuPySDyEuOHXqoScF8TKVmI1ci9Ps8O2Nuj6GiJvKxrYSp-iPmGG64M97zGBY4b0q1z1tCxHjRDHqVXyAo29Hbx1O6cOwo8nYqTEfvIMwita-ZZP2jVVy7YohW8rWcXOZqLfqszPNvXycda5Srf5KQ5naim_v4Xm-N_jukGuTZzSGmnQtBNsmTLW2S1W_eBu01-7xWYdShLO5x-paZOn8EJpcOcDuxYy9EEyYmo1IVBkTE8Qg3FyhVqAQhg2CwdnhXG0vVsq9fZ2KQwmtHC-eDXj5_Ze_ed1JjyWJR0PVw4-Q3A62Q7YCg2qCwN7W_2QcQUA_c3zv-eifS63Q0Kv-F6EFJ8pWAp5vh_oqfFl2lhqP4M6snJjLG7hTsqdkAHEEtQV32KNA4w_jvkYHtrv5t5s6YRnmYQ63rtPFXcpIFUgeXShL6fpxAFcZ7owJe-1iljgYxUaHnOucqVDIxMcxuDnxgpFoV3yXI5LO19AreL-8pK-KgEOXqSdqyViv0UnEoW-GmDvKjhI_SMUR0be5yKigs6EDCdAqezQZ7OJUcVi8gFMs8dAucCcnyCWXdxJA77r0XyYS9lr7JjcdwgazVEBUABX_BUEBAhQzbDOL5cAsuWkUKwQe5V2D5XJ4FAFpYJqOEQeqmeYrfbw-ODfxVcI6vZfm9H7Lzpv3tIrtYJN-3oEVmejKf2MXh1E_XErd4_ka9N0w |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9NAEF5BKwEv3Ee4ukgIGqlOHHu9th-jpCEciUoPUZUHay-D1doJIZEKT_wEfiP_A4mZtZ0qqJUQD1EkexLPer_1zKxnviHkearAbKUuc3TIhcOEFziRdn0nlhG4r5EQzMdq5NGYDw_Ym8PgsMqqxFqYkh9iueGGK8M-r3GBT3XaPiMNnam85fMgvkzWGXcjRHR_d0kdBY5OScmIbeQZRNY18azrtetfrpiidbyrp-f5matuq7U7gxvkY61xmW5y3FrMZUt9_4vM8f-GdJNcr9xR2i3xc4tcMsVtcrVXd4G7Q37vZZhzKAozWXyluk6ewemkk5TmZqbEdI7URFSoTKPIDB6gmmLdCjUAAzBrhk5OM23o5nB71G1uURjMdOW49-vHz-GOPScUJjxmBd30Vw5-A-ha2S6YiSYVhabjrTGI6Cy3l7HedyUy6vWaFP7DdiCk-ELBUMzw_0RPsi-LTFP1GdQT84qvu437KSanOUQS1NaeIokDjP8uORhs7_eGTtUywlEMIl2nk8aS69gT0jNcaN910xhiIM4j5bnCVSpmzBOB9A1POZepFJ4WcWpC8BIDyQL_HlkrJoV5QOB2cVcaAR8ZIUNP1AmVlKEbg0vJPDdukJc1ehJV8aljW4-TpGSC9hKYzgSns0GeLSWnJYfIOTIvLACXAmJ2jDl3YZB8GL9Kovd7MesPj5KjBtmoEZoAFPD1TgmBxGfIZRiGF0tg0TISCDbI_RLaZ-pEEMbCKgE1LEAv1DPZ7Y3w--G_Cm6QKzv9QfLu9fjtI3KtzrbpBI_J2ny2ME_ApZvLp3bt_gGgOEyL |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Simultaneous+determination+of+mercapturic+acids+derived+from+ethylene+oxide+%28HEMA%29%2C+propylene+oxide+%282-HPMA%29%2C+acrolein+%283-HPMA%29%2C+acrylamide+%28AAMA%29+and+N%2CN-dimethylformamide+%28AMCC%29+in+human+urine+using+liquid+chromatography%2Ftandem+mass+spectrometry&rft.jtitle=Rapid+communications+in+mass+spectrometry&rft.au=Schettgen%2C+Thomas&rft.au=Musiol%2C+Anita&rft.au=Kraus%2C+Thomas&rft.date=2008-09-15&rft.pub=John+Wiley+%26+Sons%2C+Ltd&rft.issn=0951-4198&rft.eissn=1097-0231&rft.volume=22&rft.issue=17&rft.spage=2629&rft.epage=2638&rft_id=info:doi/10.1002%2Frcm.3659&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_8QS94DHZ_Z |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0951-4198&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0951-4198&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0951-4198&client=summon |